Is adjuvant chemotherapy useful for soft-tissue sarcomas?

Affiliations

Comment

David D'Adamo. Lancet Oncol. 2012 Oct.

. 2012 Oct;13(10):968-70.

doi: 10.1016/S1470-2045(12)70390-X. Epub 2012 Sep 4.

¹ Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Brookline Avenue, Dana 1212, Boston, MA 02215, USA. david_dadamo@dfci.harvard.edu

No abstract available

Comment on

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Woll PJ, et al. Lancet Oncol. 2012 Oct;13(10):1045-54. doi: 10.1016/S1470-2045(12)70346-7. Epub 2012 Sep 4. Lancet Oncol. 2012. PMID: 22954508 Clinical Trial.